Current Issue

View Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences

Featured Articles

Choice of Upstream Bioreactor Technologies for Industrial Scale Viral Manufacturing (White Paper USD3244)

Pall Corporation

Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release

By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer

Overcoming Obstacles in AAV Viral Vector Manufacturing

Successful Wetting for Filter Integrity Testing in Volume-Restricted Systems

View All Featured Articles

Headline News

Roche launches VENTANA BAP1 test to support mesothelioma diagnosis

FDA places Bright Minds’ planned BMB-101 Phase II epilepsy study on partial clinical hold

Roche receives CE Mark for compact cobas smart e immunoanalyser

Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Smart machine learning solution to master industry 4.0 in biopharma

Presented by Moritz von Stosch, PhD,
11th November 2020

Successful Scale Up of a High Yielding Viral Vector Suspension Platform to 500 L

Presented by John Ketz, Process Development Senior Scientist, Andelyn Biosciences, Denis Kole, Director - AcceleratorSM Processes Development Services, Pall Corporation and Benben Song, Product Manager Services, Pall Corporation
12th July 2022

Making Virus Inactivation a Reality for Continuous Upscaled Processes

Presented by Mark Schofield, Ph.D., Principal R&D Engineer, Pall Life Sciences - Westborough, MA, USA
30th November 2017

View All Past Webinars

Featured Companies

View All Companies

Featured Video

At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.

There’s no kit for the perfect biotech process. Until now.

View All Videos